Literature DB >> 19183179

New-onset psoriasis in a patient treated with interferon beta-1a.

I López-Lerma, P Iranzo, C Herrero.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19183179     DOI： 10.1111/j.1365-2133.2008.09005.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  12 in total

Review 1.  Janus-like effects of type I interferon in autoimmune diseases.

Authors:  Robert C Axtell; Chander Raman
Journal:  Immunol Rev       Date:  2012-07       Impact factor: 12.988

Review 2.  Interferon-β exacerbates Th17-mediated inflammatory disease.

Authors:  Robert C Axtell; Chander Raman; Lawrence Steinman
Journal:  Trends Immunol       Date:  2011-04-29       Impact factor: 16.687

Review 3.  Type I interferons: beneficial in Th1 and detrimental in Th17 autoimmunity.

Authors:  Robert C Axtell; Chander Raman; Lawrence Steinman
Journal:  Clin Rev Allergy Immunol       Date:  2013-04       Impact factor: 8.667

Review 4.  Antimicrobial peptides in the pathogenesis of psoriasis.

Authors:  Shin Morizane; Richard L Gallo
Journal:  J Dermatol       Date:  2012-03       Impact factor: 4.005

Review 5.  Demyelinating disease (multiple sclerosis) in a patient with psoriatic arthritis treated with adalimumab: a case-based review.

Authors:  Marko Barešić; Mirna Reihl Crnogaj; Ivana Zadro; Branimir Anić
Journal:  Rheumatol Int       Date:  2021-09-23       Impact factor: 2.631

6.  Psoriasis during natalizumab treatment for multiple sclerosis.

Authors:  Jorge Millán-Pascual; Laura Turpín-Fenoll; Pablo Del Saz-Saucedo; Ignacio Rueda-Medina; Santiago Navarro-Muñoz
Journal:  J Neurol       Date:  2012-10-25       Impact factor: 4.849

Review 7.  The role of xenobiotics in triggering psoriasis.

Authors:  Jasna Grželj; Marija Sollner Dolenc
Journal:  Arch Toxicol       Date:  2020-08-24       Impact factor: 5.153

8.  Psoriasis during interferon beta treatment for multiple sclerosis.

Authors:  Loredana La Mantia; F Capsoni
Journal:  Neurol Sci       Date:  2009-11-19       Impact factor: 3.307

9.  Psoriasis and hepatitis C: improvement with interferon.

Authors:  Eyassu Habte-Gabr; Nicolas Lecea
Journal:  Ann Dermatol       Date:  2011-12-27       Impact factor: 1.444

10.  Cutaneous Adverse Events Associated with Interferon-β Treatment of Multiple Sclerosis.

Authors:  Annette Kolb-Mäurer; Matthias Goebeler; Mathias Mäurer
Journal:  Int J Mol Sci       Date:  2015-07-02       Impact factor: 5.923
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.